Published in Mol Nutr Food Res on February 05, 2013
Emerging therapies for food allergy. J Clin Invest (2014) 0.83
The rise of food allergy: Environmental factors and emerging treatments. EBioMedicine (2016) 0.79
Developing therapies for peanut allergy. Int Arch Allergy Immunol (2014) 0.76
B-cell epitopes in GroEL of Francisella tularensis. PLoS One (2014) 0.75
Future Therapies for IgE-Mediated Food Allergy. Curr Pediatr Rep (2014) 0.75
Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov (2006) 5.19
Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol (2007) 4.25
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol (2010) 3.49
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med (2006) 3.25
Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol (2006) 3.03
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol (2008) 2.87
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev (2009) 2.54
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol (2004) 2.48
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol (2004) 2.40
Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol (2004) 2.27
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2011) 1.84
A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol (2000) 1.84
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest (2006) 1.77
Peanut allergy. Lancet (2008) 1.72
Amino acid sequence of a mouse mucosal mast cell protease. Biochemistry (1989) 1.39
A novel model of sensitization and oral tolerance to peanut protein. Immunology (2004) 1.35
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17
Role of TLR4 in allergic sensitization to food proteins in mice. Allergy (2006) 1.14
Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. J Allergy Clin Immunol (2004) 1.07
Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol (2010) 1.05
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Methods (2006) 1.03
Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide. J Immunol (2006) 1.02
Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy (2011) 1.01
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. J Exp Med (2009) 0.94
In vivo and T cell cross-reactivity between walnut, cashew and peanut. Int Arch Allergy Immunol (2008) 0.93
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. J Allergy Clin Immunol (2007) 0.89
Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro. J Allergy Clin Immunol (2010) 0.87
Peanut allergy: an evolving clinical challenge. Discov Med (2011) 0.86
Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts. J Allergy Clin Immunol (2010) 0.85
CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Int Immunopharmacol (2007) 0.82
Oral sensitization to peanut is highly enhanced by application of peanut extracts to intact skin, but is prevented when CpG and cholera toxin are added. Int Arch Allergy Immunol (2006) 0.81
Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response. Immunol Res (2011) 0.80
Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity. J Allergy Clin Immunol (2011) 0.78
Differential polarization of immune responses by plant 2S seed albumins, Ber e 1, and SFA8. J Immunol (2006) 0.77
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol (2010) 3.49
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol (2008) 3.19
National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol (2010) 3.12
Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol (2006) 3.03
Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med (2003) 3.00
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) (2006) 2.66
The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol (2010) 2.52
Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol (2006) 2.43
The changing CARE for patients with food allergy. J Allergy Clin Immunol (2013) 2.04
Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol (2009) 1.98
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol (2012) 1.96
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol (2004) 1.68
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol (2009) 1.53
Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol (2009) 1.50
The natural progression of peanut allergy: Resolution and the possibility of recurrence. J Allergy Clin Immunol (2003) 1.49
Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics (2012) 1.48
Negative regulation of mTOR activation by diacylglycerol kinases. Blood (2011) 1.46
Regulation of T-cell survival and mitochondrial homeostasis by TSC1. Eur J Immunol (2011) 1.34
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol (2011) 1.30
Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell (2009) 1.28
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol (2013) 1.24
Safety of open food challenges in the office setting. Ann Allergy Asthma Immunol (2008) 1.24
Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci U S A (2008) 1.22
Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol (2005) 1.21
Peanut allergy: recurrence and its management. J Allergy Clin Immunol (2004) 1.16
T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex. Blood (2006) 1.15
The role of diacylglycerol kinase ζ and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. J Biol Chem (2013) 1.15
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
The role of tuberous sclerosis complex 1 in regulating innate immunity. J Immunol (2012) 1.13
Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. J Immunol (2002) 1.12
Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol (2006) 1.11
Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol (2011) 1.11
Tumor suppressor TSC1 is critical for T-cell anergy. Proc Natl Acad Sci U S A (2012) 1.11
Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression. J Immunol (2012) 1.08
Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J Exp Med (2007) 1.08
Soy immunotherapy for peanut-allergic mice: modulation of the peanut-allergic response. J Allergy Clin Immunol (2004) 1.07
Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol (2003) 1.07
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol (2013) 1.06
Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol (2010) 1.05
Critical roles of RasGRP1 for invariant NKT cell development. J Immunol (2011) 1.04
IgE-mediated food allergy in children. Lancet (2013) 1.03
Impaired degranulation but enhanced cytokine production after Fc epsilonRI stimulation of diacylglycerol kinase zeta-deficient mast cells. J Exp Med (2006) 1.02
Regulation of mast cell survival and function by tuberous sclerosis complex 1. Blood (2012) 1.01
Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol (2002) 1.01
Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development. J Immunol (2011) 1.00
CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci U S A (2012) 0.99
iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J Clin Invest (2014) 0.98
Synaptic removal of diacylglycerol by DGKzeta and PSD-95 regulates dendritic spine maintenance. EMBO J (2009) 0.98
Oral immunotherapy for food allergy. Curr Allergy Asthma Rep (2009) 0.98
A neonatal swine model for peanut allergy. J Allergy Clin Immunol (2002) 0.97
Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc Natl Acad Sci U S A (2014) 0.97
Pathophysiology of food allergy. Pediatr Clin North Am (2011) 0.95
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.94
Egg oral immunotherapy in non-anaphylactic children with egg allergy: follow-up. J Allergy Clin Immunol (2007) 0.94
Monitoring peanut allergen in food products by measuring Ara h 1. J Allergy Clin Immunol (2003) 0.93
Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA. J Immunol (2013) 0.93
Clinical characteristics of peanut-allergic children: recent changes. Pediatrics (2007) 0.93
In vivo and T cell cross-reactivity between walnut, cashew and peanut. Int Arch Allergy Immunol (2008) 0.93
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Peanut allergenicity. Ann Allergy Asthma Immunol (2004) 0.92
Chronic activation of the kinase IKKβ impairs T cell function and survival. J Immunol (2012) 0.91
Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity. J Immunol (2014) 0.91
Oral and sublingual immunotherapy for food allergy: current progress and future directions. Curr Opin Immunol (2013) 0.90
Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr Opin Allergy Clin Immunol (2009) 0.89
MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. PLoS One (2013) 0.89
The role and regulation of mTOR in T-lymphocyte function. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases. J Immunol (2012) 0.88
SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling. J Immunol (2011) 0.88
Maternal and infant diets for prevention of allergic diseases: understanding menu changes in 2008. J Allergy Clin Immunol (2008) 0.88
Regulation of Lipid Signaling by Diacylglycerol Kinases during T Cell Development and Function. Front Immunol (2013) 0.87
Omalizumab : other indications and unanswered questions. Clin Rev Allergy Immunol (2005) 0.87
Peanut protein allergens: the effect of roasting on solubility and allergenicity. Int Arch Allergy Immunol (2004) 0.86
Food allergy education for school nurses: a needs assessment survey by the consortium of food allergy research. J Sch Nurs (2010) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
Food allergies: prevalence, molecular characterization, and treatment/prevention strategies. Annu Rev Nutr (2006) 0.85
Pollen food syndrome: update on the allergens. Curr Allergy Asthma Rep (2008) 0.85
Animal models of food allergy. Curr Opin Allergy Clin Immunol (2002) 0.84
Vaccine approaches for food allergy. Curr Top Microbiol Immunol (2011) 0.84
Differential requirement of RasGRP1 for γδ T cell development and activation. J Immunol (2012) 0.84
Modification of peanut allergen Ara h 3: effects on IgE binding and T cell stimulation. Int Arch Allergy Immunol (2002) 0.84
The future of food allergy therapeutics. Semin Immunopathol (2012) 0.84
Occupational asthma symptoms and respiratory function among aerial pesticide applicators. Am J Ind Med (2003) 0.83